Y-mAbs Therapeutics Inc (NAS:YMAB)
$ 12.01 0.25 (2.13%) Market Cap: 527.03 Mil Enterprise Value: 452.46 Mil PE Ratio: 0 PB Ratio: 5.31 GF Score: 56/100

Y-mAbs Therapeutics, Inc Annual Shareholders Meeting Transcript

Jun 11, 2020 / 02:00PM GMT
Release Date Price: $40.87 (-5.06%)
Operator

Hello, and welcome to the Annual Meeting of Stockholders of Y-mAbs Therapeutics Annual Meeting 2020. Please note that today's meeting is being recorded. During the meeting, we will have a question and answer session. (Operator Instructions) Please note that your registered name will be announced along with your question during the Q&A session following the formal portion of the meeting. Guests will not be able to submit questions. (Operator Instructions)

It is now my pleasure to turn today's meeting over to Mr. Thomas Gad. The floor is yours.

Thomas Gad
Y-mAbs Therapeutics, Inc. - Founder, Chairman, President & Head of Business Development and Strategy

Thank you very much. Good morning, ladies and gentlemen, and welcome to the 2020 Annual Meeting of Stockholders of Y-mAbs Therapeutics, Inc. My name is Thomas Gad, and I'm the Chairman of the Board.

We had expected an in-person meeting this year, however, COVID-19 pandemic caused us to host a virtual meeting for the health and safety of our stockholders, employees and other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot